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Circulation of Hematopoietic Progenitors
in the Mouse Embryo
Sylvie Delassus and Ana Cumano cells have been identified at day 11 of gestation, in a
UniteÂ de Biologie MoleÂ culaire du geÁ ne structure embryologically derived from the P-Sp, the
Institut Pasteur Aorta±Gonad±Mesonephros (AGM) region (MuÈ ller et al.,
25 Rue du Dr. Roux 1994).
Paris Cedex 15 Circulating blood, in adult mice, contains few imma-
France ture hematopoietic cells. In contrast, fetal blood is rich
in progenitor cells. Cord blood can substitute bone mar-
row as a source of stem cells in human transplantations
Summary (Gluckman et al., 1989). Prothymocytes, as well as more
immature noncommitted T cell precursors, have been
We used a sensitive in vitro culture system to follow, identified in murine fetal blood from day 14.5 embryos,
in embryonic blood, the number and state of commit- but their origin has not been conclusively elucidated
ment of B cell precursors along ontogeny. We describe (Rodewald et al., 1994). Little is known, however, about
a wave of circulating multipotent progenitors, first de- the developmental potential as well as the phenotype
tectable at day 10 of gestation, and reaching a maxi- of circulating progenitors, at successive stages of gesta-
mum in absolute numbers at day 12. They are unde- tion. This is necessary information that would indicate
tectable by day 14 of gestation, when committed B cell the origin and potential differences in the hematopoietic
precursors can be detected in fetal liver. Embryonic precursors colonizing the embryo and adult hematopoi-
marrow contains B cell progenitors by day 15. We etic organs. In addition, in the absence of information
propose that fetal liver, thymus, and bone marrow are
about circulating progenitors, blood contamination is
colonized by thesame wave ofmultipotent hematopoi-
difficult to distinguish from hematopoietic precursorsetic cells and define embryonic blood at day 11 of
seeding different sites.gestation asan important source of multipotent hema-
We, therefore, studied the numbers of circulating Btopoietic cells, virtually deprived of committed and
cell progenitors from day 10 to day 18 of gestation andmature contaminants.
characterized these precursors for their expression of
surface markers and for their potential for differentiationIntroduction
into other lineages, in a clonal in vitro assay. We show
that multipotent hematopoietic progenitors can beHematopoiesis is a regulated developmental cascade
found in circulation at day 10 of development. Theirthat generates at least eight distinct lineages of mature
absolute number increases until day 12, then dropscells. The process is initiated by a pluripotent stem cell
drastically to be barely detectable at day 13. From daythat differentiates in a hierarchical array of develop-
14 on, the number of circulating progenitors increasesmental intermediate cells, consisting of multipotent and
again until day 16, but these precursors are committedmonopotent progenitors (Keller et al., 1985; Dick et al.,
to the B lineage. Bipotent B cell/macrophage precur-1985). This process takes place in the bone marrow and
sors, comprising the majority of B lineage progenitorsin the thymus of adult animals and, during embryonic
in day 11±12 fetal liver, are never found in circulation.development, predominantly in fetal liver and thymus.
Assuming that the seeding of hematopoietic organsHematopoietic precursors seed the mouse fetal liver
happens via circulation, these results suggested thataround day 10 of gestation (Houssaint, 1981; Johnson
bone marrow, the definitive adult hematopoietic site,and Moore, 1975), while the embryonic thymus (originat-
ing from the third branchial pouch) is colonized some- might be colonized by multipotent hematopoietic pre-
what later, starting at day 10.5 (Fontaine-Perus et al., cursors before day 14 of gestation, by the same wave
1981; Jotereau et al., 1987; Owen and Ritter, 1969). that colonizes fetal liver and fetal thymus. We, therefore,
Spleen is thought to be colonized around day 15, while analyzed embryonic marrow anlage, before bone forma-
bone marrow colonization would take place around day tion. We show that this organ is already colonized at
16 of development (Ogawa et al., 1988). day 15 of development. The increase in the numbers of
The development of hematopoietic cells in fetal liver, B cell progenitors is slow from day 15 to day 17, then
thymus, spleen, and bone marrow relies on an inflow of thereafter is exponential, indicating that active lympho-
blood-borne stem cells (Le Douarin, 1984; Moore and poiesis starts in bone marrow at day 17 of gestation,
Owen, 1967). A number of hematopoietic organs have 3±4 days after colonization.
been studied during embryonic development as the po-
tential origin of stem cells, including yolk sac, omentum,
Resultsplacenta, and undefined portions of the embryo (Melch-
ers, 1979; Ogawa et al., 1988; Paige et al., 1979; Raff et
The Number of Circulating B Cell Precursorsal., 1976; Solvason et al., 1991; Tyan and Herzenberg,
Increases from Day 10 to Day 12 of Development1968). More recently, intraembryonic multipotent cells
and They Are All Multipotent Hematopoietic Cellshave been detected around day 9 of development, i.e.,
Frequencies of B Cell Progenitors in Blood,prior to liver colonization, in the paraaortic splanch-
Placenta, and Fetal Livernopleura (P-Sp), their detection being parallel with that
B cell precursors have been previously detected in theof multipotent progenitors in the yolk sac (Godin et al.,
1995). Long-term reconstituting hematopoietic stem placenta prior to liver colonization (Melchers, 1979). We
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except for the blood progenitors at day 10 of develop-
ment. This variation can be explained by the difference
of several hours in the time of development of indepen-
dent pregnancies, or by the limiting numbers of precur-
sors, or a combination of both.
To study whether the circulating B cell precursors
represented a special subpopulation of the liver-derived
progenitors, we determined the percentage of the
blood- and liver-derived B cell precursors that ex-
pressed the B220 and the Ly6A/Sca1 markers. At day
10 of gestation, all the circulating progenitors were
Sca12, as had already been shown for the embryo-de-
rived precursors (Cumano et al., 1993), and the majority
(65%) were still Sca12 at day 12, which is not signifi-
cantly different from fetal liver (Cumano et al., 1992). AtFigure 1. Quantification of B Cell Precursors in the Placenta, the
Blood, and the Liver or Total Body of the Embryo at Different Devel- day 12 of gestation, we could not detect any B2201
opmental Timepoints precursor in the circulation that, given the low number
Frequencies and total numbers of B cell progenitors were evaluated of precursors per embryo, correlates with what was pre-
by limiting dilutions of enriched AA4.11 populations. The different viously observed in the fetal liver (Cumano and Paige,
points from the same sample correspond to independent experi-
1992). Thus, the circulating precursors could not be dis-ments where cell suspensions were prepared from 4±10 pooled
tinguished from the liver-derived progenitors on the ba-embryos from the same litter. At days 11 and 12, cells suspensions
sis of the expression of these surface markers.were prepared from liver alone, while the whole embryo was used
at days 9 and 10. Response to LPS Stimulation
Lipopolysaccharide (LPS) stimulation of B cell precur-
sors developing in vitro leads to their differentiation into
studied the frequencies of B cell progenitors isolated plasma cells and to immunoglobulin secretion (Cumano
from blood, placenta, and fetal liver from embryos at et al., 1990). Owing to allelic exclusion in mature B
different stages of gestation. Cells were obtained from cells, the progeny of a LPS-stimulated B cell from a
placenta and fetal liver between days 9 and 12 of gesta- Igh6a 3 Igh6b F1 hybrid mouse will express only one of
tion and from embryonic blood between days 10 and the immunoglobulin heavy chain allotypes. By analyzing
12. Cells were enriched by panning according to their the immunoglobulin M (IgM) allotype secreted by a clone
specific adherence to AA4.1 monoclonal antibody±
of cells, we can make sure of the functionality as well
coated plates. This surface marker was previously
as of the fetal origin of the B cell precursors, and can
shown to be expressed in all hematopoietic stem cells
distinguish between two different stages of differentia-
and multipotent precursors isolated from total embryos
tion of these precursors (Sauter and Paige, 1988). Thus,
from the stage of 25 pairs of somites (day 9.5 of develop-
allotype-uncommitted cells that have not undergone a
ment) (Godin et al., 1995) until day 14 of development
stable VH±D±JH rearrangement will generate clones that(Cumano and Paige, 1992; Jordan et al., 1990).
will produce both immunoglobulin allotypes, while in
These different samples were tested in a limiting-dilu-
contrast, more differentiated cells will generate progenytion assay, using culture conditions that favor the devel-
producing a single allotype. Furthermore, there is a cor-opment of B cell progenitors (Sudo et al., 1989; Rolink
relation between the stage of development of a pre-et al., 1991; Cumano et al., 1992; Collins and Dorshkind,
cursor and the time in culture required for acquisition1987). The results of nine independent experiments in
of LPS responsiveness: in day 12 fetal liver, thewhich the total numbers of B cell progenitors in the
AA4.11B2201 B cell progenitors, which exhibit D±JH re-placenta, blood, and embryo or fetal liver were evaluated
arrangements (Cumano and Paige, 1992), acquire re-are shown in Figure 1. B cell progenitors were detected
sponsiveness to LPS after 6 days in culture, while thein the blood as early as day 10 of gestation, whereas
AA4.11B2202 precursors, which have not completedthey were found in placenta only at day 11. From day
D±JH rearrangements and are mostly uncommitted in10 to day 12, the number of blood-derived precursors
the B lineage pathway of differentiation, do not respondas well as the number of precursors detected in the
to LPS before 9 days in culture (Cumano et al., 1993).placenta increased linearly, while the number of liver-
To ensure that we were studying the progeny of a singlederived progenitor cells increased exponentially (Figure
precursor, the LPS stimulation analyses were performed1). These results are compatible with previous estima-
on limiting dilution cultures.tions of numbers of precursors in fetal liver (Cumano et
Day 11 precursors exhibited a difference in the kinet-al., 1992) and indicate that production of B cell precur-
ics of LPS responsiveness depending on their origin. Allsors starts in the fetal liver at day 10 of gestation. In
(46 of 46) the fetal liver±derived precursors secreted IgMcontrast, the linear increase in thenumber of progenitors
in response to LPS at day 11 after initiation of the culturedetected in the placenta indicates that no active lympho-
(Table 1, day 11 embryo). In contrast, 30% (11 of 37) ofpoiesis is taking place there and suggests that these
the blood-derived precursors required 14 days in cultureprecursors are likely to be circulating progenitors.
to acquire LPS responsiveness. This difference indi-The numbers of precursors detected in the different
cates that the immature progenitors are present at asamples as well as the ratios between the different pop-
ulations did not vary much in individual experiments, higher frequency in the blood-derived than in the fetal
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Table 1. Kinetics of LPS Responsiveness and Heavy Chain Allotypes Secreted by Clones of AA4.11 Precursors
Number of clones secreting immunoglobulin
Developmental Culture time prior to
stage Tissue analyzed LPS stimulation (days) IgM IgMa1b IgMa IgMb
Day 11 embryo Blood 11 26 26 0 0
Blood 14 37 37 0 0
Fetal liver 11 47 46 1 0
Fetal liver 14 47 46 1 0
Day 14 embryo Blood 4 14 12 0 2
Blood 7 17 14 2 1
Blood 8 13 13 0 0
Fetal liver 4 40 39 1 0
Fetal liver 7 37 37 0 0
Fetal liver 8 48 46 2 0
Clones from enriched AA4.11 populations from blood or fetal liver were analyzed sequentially for their ability to respond to LPS stimulation
and for allotype heavy chain expression. Only clones that secreted immunoglobulin are shown.
AA4.11 cells from eight pooled day 11 embryos from the same litter were set in pre-B cultures at a density ensuring the clonality of the
assay, in two 96-well plates per sample (blood and liver). At day 11 after initiation of the culture, half of the cells from each well were transferred
to freshly irradiated S17 cells and stimulated with LPS. The remaining half was completed with IL-7 containing medium. Clones were stimulated
3 days later by removing the medium and providing them LPS containing medium. ELISA was performed 12 days after the stimulation.
Clones from day 14 embryos were analyzed for LPS responsiveness and allotype expression after 4, 7, or 8 days in culture. Blood sample
corresponded to 10 pooled embryos from the same litter, while fetal liver cells came from a single embryo. AA4.11 cells from blood and liver
were plated in 7 and 14 plates, respectively, at a density ensuring clonality. At each day between days 4 and 10 after initiation of the culture,
one plate from blood sample and two from liver were stimulated with LPS. Days 5 and 6 provided similar results to days 4 and 7, while days
9 and 10 were identical to day 8 (data not shown).
liver±derived precursors. No significant differences were subpopulation of the fetal liver±derived progenitors. Be-
fore day 12 of development, we could only detectobserved at the level of allotype commitment.
multipotent precursors in circulation.Potential of Differentiation
It has been previously shown that, in day 12 fetal liver,
half of the AA4.11B2202 B cell precursors are bipotent By Day 13 the Number of Circulating B Cell
uncommitted cells that can generate macrophages and Precursors Decreases Drastically, and
B cells but have lost the potential to differentiate into Thereafter They Are Mainly Composed
other myeloid lineages (Cumano et al., 1992). To see of Committed Progenitors
whether the different kinetics of response to LPS were As gestation progresses, the numbers of B cell precur-
a reflection of different stages of commitment, we deter- sors detected in the different compartments change.
mined the differentiation capacity of the blood- or fetal Experiments performed with day 13 or 14 embryos
liver±derived precursors detected at day 11 of gestation. showed that thenumber of B cell precursors in the blood
We expanded individual clones of blood- and fetal liver± was 10-fold lower than the one previously found at day
derived precursors under culture conditions that allow 12, while the number of progenitors detected in the liver
multipotent cells to develop and to differentiate into all (Table 3), as well as the number of total cells collected
hematopoietic lineages (see Experimental Procedures) from blood and liver, were still increasing exponentially
(Cumano et al., 1992; Godin et al., 1995). Two types of (Figure 3). Thereafter, the number of B cell precursors
clones were identified: first, multipotent clones, which in the blood increased from 10 per embryo, at day 14,
were positive for immunoglobulin secretion and showed to 400±1,000 per embryo, at day 16. As B cells mature,
differentiation into macrophages, megakaryocytes, and they lose the capacity to respond to interleukin-7 (IL-7)
granular polymorphonuclear cells (Figure 2B). These and cannot be detected in our assay. The first mature
clones were also capable of generating T cells when B lymphocytes appear in the fetal liver around day 17 of
cells were assayed in a fetal thymic organ culture development (Raff etal., 1976). These cells can circulate,
(FTOC), generating CD4/CD8 single-positive as well as and in the adult, they represent the vast majority of B
double-positive T cells (Figure 2A) (Godin et al., 1995); lineage cells detected in the blood. Thus, the decrease
second, bipotent precursors, that developed into B lym- in the frequency of circulating B cell precursors at day
phocytes and macrophages, but in no other myeloid 18 may be due to the dilution of these progenitors in a
lineage (Figure 2C) (Cumano et al., 1992), and were also population mainly composed of mature cells.
unable to generate T cells in FTOC (A. C. et al., unpub- Hematopoiesis in fetal liver starts at day 10 of gesta-
lished data). The relative repartitions of these two types tion, and the first committed B lineage progenitors can
in the different samples are summarized in Table 2 (day be detected by day 12±13 (Cumano and Paige, 1992).
11). All the blood-derived clones appeared to be Assuming that circulating precursors are from liver ori-
multipotent, as well as 55% (7 of 13) of the liver-derived gin, the decrease in their absolute numbers at day 13
clones. Nevertheless, in the remaining cultures from of gestation is a surprising finding. At day 11, circulating
liver, only macrophages could be detected. Thus, the B cell precursors corresponded to a multipotent cell
population that did not match the potential of fetal livercirculating B cell precursors do not represent a random
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cells. It was therefore interesting to study whether the
evolution in the developmental stage of precursors in
fetal liver was reflected in circulation, at later stages.
We thus characterized the progenitors isolated from
blood and fetal liver from day 14 embryos for their stage
of lineage commitment.
The differences of kinetics of responsiveness to LPS
between the blood- and fetal liver±derived precursors
that had been observed at day 11 was reversed at day 14
of gestation. Data presented in Table 1 (day 14 embryo)
show that while most of the blood-derived precursors
were responsive to LPS after only 4 days in culture, a
significant part of the fetal liver±derived precursors
(25%) did not respond to LPS before 8 days in culture.
Furthermore, while 20% of the clones derived from
blood expressed only one immunoglobulin allotype, only
5% of the clones derived from fetal liver were allotype
committed. These results indicate that, at day 14 of
development, the circulating progenitors correspond
mainly to the fetal liver precursors that are the most
advanced in differentiation.
We then examined the day 14 blood- and fetal liver±
derived progenitors for their capacity to differentiate in
multiple lineages. Results are summarized in Table 2
(day 14). In these experiments, a third type of clones
was detected in comparison to the experiments per-
formed with the day 11 embryos: committed B cell pre-
cursors, which were unable to differentiate in any other
cell type under the different conditions of culture. From
day 14 embryos, 27 liver-derived clones that could dif-
ferentiate into mature B cells were analyzed in myeloid
culture conditions. Of these cultures, 20 (74%) were
negative, indicating that the precursors giving rise to
these clones were already committed to the B lineage.
Of the remaining 7 clones, 2 differentiated into macro-
phages and megakaryocytes, and 5 gave rise only to
macrophages. From the 6 blood-derived clones, 5 were
B lineage committed, while 1 generated a few macro-
phages 2 weeks after the initiation of culture. Thus, no
multipotent or unambiguous bipotent clones could be
identified from the blood-derived cultures. We conclude
that, in latter stages of development, circulating progeni-
tors are mainly composed of committed B cell pre-
cursors.
Figure 2. Analysis of Cells Derived from Clones Obtained in Limiting In Embryonic Marrow, HematopoieticDilution Conditions
Colonization Is Detectable at Day 15
Clones were obtained from the enriched AA4.11 population from
and B Lymphopoiesis Starts to Beblood or liver from a day 11 embryo by culture on irradiated stomal
Active after Day 17cells in the presence of IL-7, IL-11, and c-kit ligand in limiting dilution
conditions. After 11 days in culture, clones positive for the presence The decrease in the circulation of multipotent progeni-
of lymphocytes were divided in different culture conditions (see tors after day 12 raised the problem of the colonization
Experimental Procedures). of bone marrow, which is assumed to take place later
(A) CD4/CD8 staining of a clone, 14 days after transfer in FTOC.
in development by an inflow of blood-borne stem cellsOne-third of the blood-derived clone S1D3 was transferred in FTOC.
arising from the fetal liver. As described in Experimental(B) May±GruÈ nwald±Giemsa staining of the same S1D3 clonegrowing
Procedures, marrow cells can be collected from dayin myeloid conditions. After a further 5 days of culture in myeloid
conditions after division of the initial culture, cells were spotted on 15 embryos from the inside of a tubular cartilagineous
a slide and stained. structure that defines the place where bone will develop.
(C) May±GruÈ nwald±Giemsa staining of B cell/macrophage clone We thus analyzed the presence of B cell precursors in
A12, derived from the enriched AA4.11 population of fetal liver from embryonic marrow anlage at day 15 of gestation. As
a day 11 embryo, and growing in the myeloid conditions. Closed
progenitors are present in circulation, it was importantinverted triangle, granular polymorphonuclear cell; small arrow,
to compare, at the same stage of development, theerythrocyte precursor; closed arrowhead, macrophage; thick line,
lymphocyte. frequencies of progenitors in marrow and in blood to
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Table 2. Differentiation Potential of B Cell Precursors from Blood and Fetal Liver
Percent of commited
Number of multipotent Number of bipotent precursors precursors
Cell sample precursors (Macrophages and B cells) (B cells only)
Day 11 blood 9/9 9/0 0/9
Day 11 liver 7/13 6/13 0/13
Day 14 blood 0/6 1/6* 5/6
Day 14 liver 2/27 5/27 20/27
Clones obtained under limiting dilution conditions from blood and fetal liver from embryos at day 11 (top) or 14 (bottom) of development were
analyzed for their capacity to differentiate into different lineages. Only clones growing in B lymphocyte conditions are shown.
The asterisk indicates the bipotent clone detected in day 14 blood, which exhibited a significant delay in growth compared with the bipotent
progenitors from fetal liver. As committed precursors from both origin also show a similar growth delay when compared with multipotent and
bipotent clones, this day 14 blood-derived clone was considered to be more committed than the liver-derived bipotent precursors.
ensure that the precursors detected in marrow were the expression of the AA4.1 marker. The bone marrow
pluripotent hematopoietic stem cells from adult mousenot derived from contaminating blood. In an experiment
performed with a day 15 embryo previously bled, B cell have been demonstrated to be Thy-1loLin2Sca-11
(Spangrude et al., 1988) and they are also AA4.12 (Trevi-progenitors could be detected in marrow at a frequency
13-fold higher than in the embryonic blood, demon- san and Iscove, 1995). We thus studied the enriched
AA4.12Sca-11 population aswell as the enrichedAA4.11strating that the progenitors detected in marrow did not
represent the blood population present in this organ population in fetal liver, blood, and bone marrow from
day 17 and 18 embryos for their potential to generate(Table 3). This result indicates that marrow had already
been colonized before day 15 of development, i.e., prior B cells in vitro. Results are summarized in Table 3.
AA4.12Sca-11 B cell precursors could be detected into bone development.
We determined when active lymphopoiesis starts in the bone marrow and fetal liver, but not in the blood,
although they represented a minor population comparedthe embryonic marrow by studying the evolution in the
number of bone marrow B cell progenitors, thereafter. with the AA4.11 precursors. Multipotentiality experi-
ments were performed on the AA4.11 and AA4.12Sca11One of the differences between fetal liver± and adult
bone marrow±derived long-term reconstituting cells is bone marrow±derived precursors from day 17 embryos.
Table 3. Total Numbers and Frequencies of B Cell Precursors Recovered from Blood, Fetal Liver, and Bone Marrow from Day 14 to
Day 18 of Development
Day of Number of B cell precursors
Experiment gestation Tissue analyzed per embryo (frequency)
1 13 Blood 5 (1/6.5 3 105)
2 14 Fetal liver AA4.11 1.1 3 104 (1/14)
Blood AA4.11 5 (1/360)
3 14 Blood embryo number 1 10 (1/106)
Blood embryo number 2 9 (1/106)
Blood AA4.11 embryo number 3 5 (1/4,200)
4 15 Blood 600 (1/65,000)
Bone marrow 15 (1/3,800)
5 16 Fetal liver AA4.11 2.6 3 105 (1/6)
Blood AA4.11 400 (1/45)
6 16 Fetal liver AA4.11 7 3 104 (1/7)
Fetal liver AA4.12Sca11 380 (1/300)
Blood AA4.11 930 (1/12)
Blood AA4.12Sca11 ud
7 17 Fetal liver AA4.12Sca11 103 (1/66)
Blood AA4.12Sca11 ud
Bone marrow AA4.11 42 (1/12)
8 18 Fetal liver AA4.12Sca11 8 3 104 (1/20)
Blood AA4.12Sca11 0
Bone marrow AA4.12Sca11 40 (1/25)
9 18 Fetal liver AA4.11 1.9 3 105 (1/22)
Blood AA4.11 ,1/500
Bone marrow AA4.11 2.5 3 103 (1/20)
Cells recovered from the different tissues were plated in 96-well plates with irradiated S17 cells and IL-7. Most clones identified as containing
B cell precursors by microscopic inspection were stimulated by LPS, and their ability to secrete immunoglubulin was tested by an ELISA
assay.
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composed of multipotent precursors, able to differenti-
ate into myeloid lineages and Band T lymphocytes when
cultured under appropriate conditions. These precur-
sors are first detected at day 10 of gestation, and their
absolute numbers increase until day 12. The second
wave appears at day 13 of gestation and is composed
of committed B cell precursors.
The detection and quantitation of circulating progeni-
tors as early as day 10 of development provides
evidence that the assay used in this study is a more
sensitive alternative system to detect multipotent hema-
topoietic cells to long-term reconstitution of irradiated
recipients. The number of progenitors detected here
explains the discrepancy with previous studies (MuÈ ller
et al., 1994). According to the results reported here,
day 11 fetal liver contains ten times more multipotent
precursors than blood. It is, therefore, not surprisingFigure 3. Total Number of Cells per Embryo in Liver and Blood
that, in the MuÈ ller et al. (1994) experiments, none ofThe total number of cells that can be collected from fetal blood or
the 9 mice injected with blood-derived cells showedfetal liver has been represented as a function of time of development.
During embryonic development, most erythrocytes are immature reconstitution, while under the same conditions, fetal
and still nucleated. Their exclusion by microscopic inspection is liver cells were capable of reconstituting only 40% of
thus quite difficult. The number of cells collected by bleeding was the injected mice. We are, however, aware that the in
considered consistent because no more than a 2-fold variation was
vitro assay used does not test for self-renewability and,observed in the number of blood cells collected from individual
consequently, we refer to the precursors detected asanimals at the same stage of development.
multipotent hematopoietic cells and not as stem cells.
The environment required for hematopoiesis is certainly
different in adult bone marrow and day 11 embryonic
Out of the 6 AA4.12 and the 60 AA4.11 clones derived
fetal liver. Bona fide hematopoietic stem cells isolated
from these cultures, no multipotent or bipotent clone
from an early embryonic environment might also not be
could be identified, indicating that none of these popula- able to reconstitute an adult irradiated bone marrow.
tions were enriched for noncommitted precursors in The existence of multipotent precursors unable to guar-
comparison to the liver or blood populations. The num- antee long-term reconstitution of irradiated recipients
ber of B cell progenitors rose slowly from day 15 to has been proposed (Trevisan and Iscove, 1995; Jordan
day 17 of development, then increased exponentially
et al., 1990), while otherstudies suggest that multipoten-
between day 17 and 18. This result indicates that lym-
tiality is mainly found in long-term reconstituting precur-
phopoietic progenitors accumulate in marrow from day
sors (Snodgrass and Keller, 1987; Keller and Snodgrass,
14 or earlier on, but active B lymphopoiesis at that site
1990).
does not start before day 17.
The decrease in the number of circulating hematopoi-
etic precursors between days 12 and 13 of gestation
Discussion indicate that few (if any) multipotent and noncommitted
progenitors are allowed to exit the fetal liver. Rodewald
It is generally accepted that during embryonic develop- et al. (1994) have shown that in day 14.5 fetal blood, only
ment, the different lymphoid and hematopoietic organs a minority of cells (6%) corresponded to the phenotype
are seeded by circulating hematopoietic stem cells. The Thy12c-kit1 that could reconstitute multiple hematopoi-
existence of circulating hematopoietic cells at day 9 etic lineages upon transfer, more than 70% of the circu-
of gestation has been previously suggested by their lating progenitors being already committed T or B
capacity to cure anemia in W/Wv mice (Toles et al., (B2201) cell precursors.
1989). More recently, however, long-term reconstitution At day 12 of gestation, lymphopoiesis is active in the
assays failed to detect multipotent stem cells in blood liver, and the first differentiation events appear at that
of day 10±11 embryos (MuÈ ller etal., 1994). In the absence site. Nevertheless, between day 11 and day 14, the total
of quantitative data on the circulating progenitors and number of liver-derived multipotent progenitors is still
their hematopoietic potential at different stages of ges- increasing (from 50 per embryo at day 11 to about 700
tation, it is difficult to determine the origin of hematopoi- per embryo at day 14). Thus, the observed decrease in
etic precursors and the time of colonization of different the number of circulating progenitors is compatible
organs. We used an in vitro clonal system that allows with thehypothesis that only committed progenitors can
the development of all hematopoietic lineages to ad- exit the fetal liver, since few committed cells are present.
dress this question. We studied the total number of the Then, as differentiation progresses, committed B cell
B cell progenitors in circulation, in comparison with that precursors from fetal liver are generated and released
in the fetal liver and bone marrow, from day 10 of the in circulation. These data suggest that the differentiation
embryonic development until day 18, as well as the mechanisms involve the expression of adhesion mole-
differentiation potential of these cells. cules, important for the hematopoietic function in a par-
Our studies identify two waves of circulating precur- ticular microenvironment. The c-kit receptor and its li-
gand are known to influence the behavior of verysors in the mouse embryo (Figure 4). The first wave is
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Figure 4. Overview of Embryonic Hematopoiesis
This figure summarizes the evolution in numbers and potentiality of development of circulating B cell progenitors along the development of
the embryo. Colonization events are plotted on the same development scale. The hypothetical statements are indicated in italics.
immature hematopoietic cells (Yasunaga et al., 1995; in the placenta, but their detection was one day delayed
from that in circulation, and their increase comparableOkada et al., 1991; Ogawa, 1993; Kodama et al., 1992).
Recently, deficiencies in primitive B lymphoid progeni- to the one observed in blood. At this stage, the placenta
has a rich blood supply, making it possible that thetors, as well as in T cell and myeloid reconstitution, have
been described in mice deficient in flk2 (Mackar- previously described placenta-derived B cell precursors
(Melchers, 1979) are in fact contaminating blood pre-ehtschian et al., 1995). These molecules have been
shown to be implicated in the regulation of proliferation cursors.
Colonization of bone marrow is believed to take placeand differentiation of stem cells. They could, in addition,
be responsible for the circulation potential of stem cells. around day 16 of gestation (Ogawa et al., 1988). Our
data show that hematopoietic precursors have alreadyOur data suggests a new model for hematopoietic
development and colonization of the different embry- accumulated in the marrow before day 15 of develop-
ment, i.e., prior to bone formation. However, active Bonic hematopoietic organs that is summarized in Figure
4. We propose that the multipotent hematopoietic pro- lymphopoiesis does not appear before day 17. The slight
increase of B cell precursors, from day 15 to day 17, isgenitors originate from the P-Sp and accumulate in the
AGM region, which derives from the P-Sp. The demon- likely due to the accumulation of circulating progenitors.
Assuming that the seeding of the hematopoietic organsstration that hematopoietic stem cells are not detected
after day 12±13 in the AGM region (Dzierzak and Medvin- requires the circulation of progenitors, it is therefore
possible that the colonization of all hematopoietic or-sky, 1995), together with the fact that no active hemato-
poiesis has ever been observed in this location, support gans occurs early in the development, from a single
intraembryonic source, but that active hematopoiesisthis hypothesis. P-Sp and, later, the AGM region are the
only sources of intraembryonic hematopoietic progeni- begins at different times in these organs, depending on
the development of the hematopoietic environment. Thetors at day 8.5, and these precursors are multipotent
(Medvinsky et al., 1993; MuÈ ller et al., 1994; Godin et al., proliferation and differentiation of the progenitors could
be linked to sufficient environmental conditions, particu-1993, 1995). These stem cells are released in embryonic
circulation as soon as day 9±10 and colonize the differ- larly to stromal cell environment, which is known to
be essential for lymphopoiesis and hematopoiesis inent hematopoietic organs between day 10 and day 13.
Fetal liver, thymus, spleen, and bone marrow would then general (Kincade et al., 1989).
Usual sources of multipotent cells either contain abe colonized between days 10±13 of gestation by stem
cells of identical origin. Multipotent cells in the yolk sac large proportion of more mature precursors from which
stem cells cannot be easily isolated or, as in the casehave been detected only after circulation is established,
around day 9 of gestation. In parallel to the avian model, of the P-Sp and the AGM region, require anatomical
microdissection. The data presented indicate that daywe suggest that the yolk sac±derived hematopoietic
stem cells are circulating cells of intraembryonic origin. 11±12 embryonic blood, containing mainly multipotent
progenitors, is a privileged source for the isolation ofSimilarly, in our study, someprecursors have been found
Immunity
104
(48 or96) were used for each celldilution. On day6, half of media wasthis cell type. It is now a priority to determine whether
removed and replaced by freshly prepared cytokine-supplementedsuch cells have similar long-term reconstituting capacity
media. Growth of small nonadherent lymphocytes was scored afteras fetal liver± or bone marrow±derived stem cells once
10±14 days. Usually three 3-fold dilutions were used. Frequencies
injected, in comparable numbers, in an adult or fetal were determined according to the Poisson distribution.
hematopoietic environment. Two experiments were conducted with the two populations of
AA4.11 and AA4.12 cells. According to previous results, no B cell
precursors could be detected in the AA4.12 fraction in day 12 fetalExperimental Procedures
liver.
Determination of Differentiation PotentialCell Preparation
The potential of the precursors to differenciate into hematopoieticExperiments were performed with animals bred in Pasteur Institute
lineage was tested by providing them with different factors. AA4.11animal facilities. F1 embryos (C57BL/6 3 BALB/c) were used to
cells isolated from day 11 blood and fetal liver and from day 14 fetaldistinguish the maternal and fetal precursors, on the basis of the
liver were plated at 1 cell per well, and cultured in the presence ofIgM allotype secretion. Timed pregnancies were determined as pre-
IL-7, IL-11, c-kit ligand and irradiated S17 stromal cells. Given theviously described (Cumano et al., 1990); the day the vaginal plug
low frequency of B cell precursors in day 14 AA4.11 blood cells,was observed was considered as day 0. Cell suspensions were
this sample was plated at the density of 16 cells per well. Growthprepared from various organs and viable cells were determined
of cells (any except the S17 stromal cells) was scored after 10 days.using trypan blue exclusion.
Less than 30% of wells were positive, which indicates that 97% ofAfter washing of the uterus and embryos to get rid of maternal
the positive cultures arose from a single precursor (Steinberg andblood, embryonic blood cells were collected by cutting the cord
Lefkovits, 1985). To ensure further the clonal origin of the cells fromwithout damaging the embryo. Embryos were then left bleeding in
a single well, positive wells were checked by microscope and onlymedium until they were completely pale.
cultures containing single clones were considered. Furthermore,Day 15 marrow was collected from hindlimbs. At that stage of
comparison of blood and liver samples were performed on experi-development, a cartilagineous tube defines the place where the
ments at the same frequency of growth.bone will develop. After careful washing of the limbs, to avoid blood
After 10±13 days in culture, the clones were split in two. Half ofcontamination, the circular channel inside this cartilagineous struc-
each clone was tested for myeloid cell differentiation: after a furtherture was flushed with medium with a 0.45 3 10 needle to collect
10 days in culture in the presence of IL-11 and c-kit ligand, thesethe marrow cells.
cells were cytospun and analyzed by a May±GruÈ nwald±Giemsa
staining. The other half was replated on S17 cells in the presencePanning Procedure
of IL-7 to support pre-B cell growth and differentiation. Cells grownPanning was done as described (Kincade et al., 1981) in Optilux 100
under this condition were stimulated with LPS, and immunoglobulinmm plastic petri dishes (Falcon). For these experiments, the two-
secretion was detected by enzyme-linked immunosorbent assaystep procedure to coat plates with antibodies described by Cumano
(ELISA). In one of the experiments performed with day 11 embryos,and colleagues (Cumano et al., 1990) was used. The first coating
one-third of the cells from each clone was also put in FTOC to studyantibody was an affinity-purified mouse anti-rat IgG (10 mg/plate)
the potential of differentiation in the T lineage.(Jackson Immunoresearch Laboratories, Jackson, Maine). The
LPS Stimulationplates were then subsequently incubated with saturating amounts
Day 11 AA4.11 cells derived either from blood or from fetal liver
of supernatant from the cell line 14.8 (anti-B220) (Kincade et al.,
were seeded in culture as described above at a frequency that
1981)), or from rat hybridomas producing either anti-Ly6 (Sca-1)
ensured the clonality of B cell precursors. On day 11 after beginning
(Spangrude et al., 1988), anti-AA4.1 (McKearn et al., 1985), or anti-
of culture, half of the cells from each well were transferred on freshly
Mac1 (M1/70) antibodies. Nonadherent cells were recovered by two irradiated S17 stromal cells in a 96-well plate and stimulated with
gentle washes with ice-cold Earle's balanced salt solution, 2% fetal LPS (Salmonella typhosa WO901; Difco), at the final concentration
calf serum. Adherent cells were recovered by using a rubber police- of 25 mg/ml, in a final volume of 200 ml/well. The remainder half was
man, either directly or after additional washes (between 6 and 8, fed with complete medium and IL-7 for 3 more days of culture. On
depending on the enrichment required and the number of cells prior day 14, these cells were also stimulated with LPS.
to panning). For the day 14 embryo experiment, AA4.11 cells from blood or
fetal liver were seeded in 96-well plates at a density that ensured the
Cytokines clonality of B cell precursors and cultured in presence of irradiated
IL-7 was obtained from J558 myeloma cells transfected with cDNA stromal cells and IL-7. Medium was removed and replaced by LPS
(gift from A. Rolink, Basel) and was titrated on the 2E8 IL-7-depen- containing medium in one plate for each sample at each day be-
dent cell line, a gift from P. Kincade. A final concentration of 50±100 tween day 4 and day 9 after culture.
U/ml was used. The c-kit ligand (also called stem cell factor) was Supernatants were checked for the presence of immunoglobulin
obtained from stably transfected CHO cells with the cDNA for c-kit of both allotype on day 12 after stimulation.
ligand (Genetics Institute, Boston, Massachusetts), the supernatant FTOC
was titrated on c-kit ligand-dependent mast cells from bone marrow FTOCs were performed as described (Jenkinson et al., 1982). In all
and used at a 1:500 dilution. IL-11 was obtained from COS-7- these experiments, thymic lobes from congenic B6/Ly5.1 (obtained
transfected cells (gift from R. Holey, Toronto), titrated in a B cell/ from the Centre National de la Recherche Scientifique colony at
macrophage precursor assay in the absence of S17 stromal cells OrleÂans, France) were used, while all the donor cells were Ly5.21.
as described by B. Kee (Kee et al., 1994), and used at a 1:100 Thymic lobes from day 15 embryos were put in Earle's balanced
dilution. salt solution (GIBCO BRL) and irradiated with 3,000 rads. Cells from
limiting dilution cultures were distributed in 4±6 wells each of a
Culture Conditions Terasaki plate in a maximum volume of 25 ml. Clonal origin of the
Determination of B Cell Precursor Frequencies cultures was careful checked as described in the determination of
The limiting dilution cultures from different fetal origins were set up differentiation potential section. One thymic lobe per well was
as previously described (Cumano et al., 1990). In brief, about 2 3 added, and the plate was hung drop at 378C, 5% CO2 for 48 hr. The
103 cells of clonal stromal cell line, S17, were seeded in each well lobes were then transferred onto a filter (0.8 mm, Millipore) in a Petri
of a 96-well plate (Costar, Cambridge, Massachusetts) and cultured dish containing 3 ml of Opti-MEM, 10% FCS, and kept in culture
overnight. The plates were irradiated at 2,000 rads by using a cesium for 12±19 days. The thymic lobes were then dissected and cell
g irradiator. Cells from the different samples at a specified dilution suspensions were stained and studied by flow cytometry.
were subsequently added at a final volume of 200 ml, in Opti-MEM
(GIBCO BRL) (Cumano et al., 1990) supplemented with 10% fetal ELISA Assay
calf serum (FCS), 100 IU/ml penicillin, 100 mg/ml streptomycin, 5 3 ELISA assays were done by coating Nunc-Immuno Plate MaxiSorp
with 5 mg/ml of affinity purified anti-mouse m chain (Sigma, St Louis,1025M 2-mercaptoethanol and recombinant IL-7 (rIL-7). Replicates
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Missouri) or protein G±purified AF6 (anti-mouse ma) (Schuppel et al., Lehn, P., Cooper, S., English, D., Kurtzberg, J., Bard, J., and Boyse,
E.A. (1989). Hematopoietic reconstitution in a patient with Fanconi's1987) or RS3.1 (anti-mouse mb) (Stall and Loken, 1984) antibody
overnight at 48C. Plates were blocked for 30 min at 378C with phos- anemia by means of umbilical-cord blood from an HLA-identical
sibling. New Engl. J. Med. 321, 1174±1178.phate-buffered saline, 1% bovine serum albumin followed by five
washes with water. Supernatants were applied to the plates and Godin, I., Garcia-Porrero, J., Coutinho, A., Dieterlen-Lievre, F., and
incubated for 1 hr at 378C. Plates were again washed five times Marcos, M. (1993). Para-aortic splanchnopleura from early mouse
with water and appropriate dilution of anti-mouse m coupled to embryos contains B1a cell progenitors. Nature 364, 67±70.
horseradish peroxidase (Sigma) was applied and incubated for an
Godin, I., Dieterlen-LieÁ vre, F., and Cumano, A. (1995). Emergence
additional 1 hr at 378C. After washing with water, the substrate 2,2'-
of multipotent hematopoietic cells in the yolk sac and para-aortic
azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS; Sigma) was splanchnopleura of 8.5 dpc mouse embryos. Proc. Natl. Acad. Sci.
applied and the absorbance read at 405/630 nm. In all plates, nega- USA 92, 773±777.
tive and positive controls were used. A blank readout consisting of
Houssaint, E. (1981). Differentiation of the mouse hepatic primor-phosphate-buffered saline, 1% bovine serum albumin alone instead
dium. II. Extrinsic origin of the haemopoietic cell line. Cell Diff. 10,of supernatants was also routinely included.
243±252.
Jenkinson, E., Franchi, L., Kingston, R., and Owen, J. (1982). EffectFluorescence Surface Staining and Flow Cytometry
of deoxyguanosine on lymphopoiesis in the developing thymus rudi-Cells were stained as described (Forni, 1979) with fluorescein iso-
ment in vitro: application in the production of chimeric thymus rudi-thiocyanate anti-Lyt-2, phycoerythrin anti-L3T4 (Immunocytometry
ments. Eur. J. Immunol. 12, 583±587.Systems, Becton Dickinson, San Jose, California), phycoerythrin
anti-ab, phycoerythrin anti-gd, phycoerythrin anti-B220 (Phar- Johnson, G., and Moore, M. (1975). Role of stem cell migration in
mingen, California), fluorescein isothiocyanate anti-m or anti-Ly5.2 initiation of mouse foetal liver haemopoiesis. Nature 258, 726±729.
antibody purified from the supernatant of the hybridoma line 104.2 Jordan, C., McKearn, J., and Lemischka, I. (1990). Cellular and devel-
coupled to fluorescein (gift from A. Regnault, in our laboratory). opmental properties of fetal hematopoietic stem cells. Cell 61,
Dead cells were eliminated by propidium iodide exclusion and at 953±963.
least 5,000 events recorded per sample. Fluorescence was mea-
Jotereau, F., Heuze, F., Salomon-Vie, V., and Gascan, H. (1987). Cellsured with a FACScan flow cytometer (Becton Dickinson, Sunnyvale,
kinetics in the fetal mouse thymus: precursor cell input, proliferation,California) with the LYSIS II software.
and emigration. J. Immunol. 138, 1026±1030.
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